Searle & Co’s CVS Health CVS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $3.06M | Buy |
29,560
+134
| +0.5% | +$12K | 0.69% | 43 |
|
|
2026
Q1 | $2.11M | Hold |
29,426
| – | – | 0.53% | 50 |
|
|
2025
Q4 | $2.34M | Sell |
29,426
-470
| -2% | -$37.1K | 0.6% | 43 |
|
|
2025
Q3 | $2.25M | Buy |
29,896
+266
| +0.9% | +$18.2K | 0.6% | 47 |
|
|
2025
Q2 | $2.04M | Sell |
29,630
-500
| -2% | -$32.8K | 0.58% | 50 |
|
|
2025
Q1 | $2.04M | Sell |
30,130
-40
| -0.1% | -$2.39K | 0.58% | 49 |
|
|
2024
Q4 | $1.35M | Buy |
30,170
+2,040
| +7% | +$114K | 0.39% | 61 |
|
|
2024
Q3 | $1.77M | Buy |
28,130
+300
| +1% | +$17.5K | 0.44% | 51 |
|
|
2024
Q2 | $1.64M | Hold |
27,830
| – | – | 0.39% | 60 |
|
|
2024
Q1 | $2.22M | Hold |
27,830
| – | – | 0.57% | 45 |
|
|
2023
Q4 | $2.2M | Hold |
27,830
| – | – | 0.6% | 44 |
|
|
2023
Q3 | $1.94M | Hold |
27,830
| – | – | 0.66% | 44 |
|
|
2023
Q2 | $2.08M | Sell |
27,830
-50
| -0.2% | -$3.56K | 0.64% | 47 |
|
|
2023
Q1 | $2.04M | Buy |
27,880
+400
| +1% | +$33.5K | 0.67% | 44 |
|
|
2022
Q4 | $2.56M | Buy |
27,480
+500
| +2% | +$48.2K | 0.87% | 35 |
|
|
2022
Q3 | $2.57M | Hold |
26,980
| – | – | 0.99% | 34 |
|
|
2022
Q2 | $2.5M | Hold |
26,980
| – | – | 0.99% | 33 |
|
|
2022
Q1 | $2.73M | Hold |
26,980
| – | – | 1.01% | 35 |
|
|
2021
Q4 | $2.78M | Hold |
26,980
| – | – | 1.01% | 36 |
|
|
2021
Q3 | $2.29M | Hold |
26,980
| – | – | 0.94% | 40 |
|
|
2021
Q2 | $2.25M | Hold |
26,980
| – | – | 0.92% | 40 |
|
|
2021
Q1 | $2.03M | Hold |
26,980
| – | – | 0.91% | 41 |
|
|
2020
Q4 | $1.84M | Hold |
26,980
| – | – | 0.89% | 43 |
|
|
2020
Q3 | $1.58M | Hold |
26,980
| – | – | 0.86% | 44 |
|
|
2020
Q2 | $1.75M | Hold |
26,980
| – | – | 1.02% | 36 |
|
|
2020
Q1 | $1.6M | Hold |
26,980
| – | – | 1.14% | 32 |
|
|
2019
Q4 | $2M | Hold |
26,980
| – | – | 1.1% | 35 |
|
|
2019
Q3 | $1.7M | Hold |
26,980
| – | – | 1% | 35 |
|
|
2019
Q2 | $1.47M | Hold |
26,980
| – | – | 0.89% | 38 |
|
|
2019
Q1 | $1.46M | Buy |
26,980
+50
| +0.2% | +$3.09K | 0.91% | 38 |
|
|
2018
Q4 | $1.76M | Hold |
26,930
| – | – | 1.24% | 31 |
|
|
2018
Q3 | $2.12M | Hold |
26,930
| – | – | 1.24% | 30 |
|
|
2018
Q2 | $1.73M | Hold |
26,930
| – | – | 1.1% | 35 |
|
|
2018
Q1 | $1.68M | Hold |
26,930
| – | – | 1.09% | 30 |
|
|
2017
Q4 | $1.95M | Hold |
26,930
| – | – | 1.23% | 25 |
|
|
2017
Q3 | $2.19M | Hold |
26,930
| – | – | 1.45% | 19 |
|
|
2017
Q2 | $2.17M | Sell |
26,930
-568
| -2% | -$44.8K | 1.49% | 16 |
|
|
2017
Q1 | $2.16M | Hold |
27,498
| – | – | 1.51% | 17 |
|
|
2016
Q4 | $2.17M | Buy |
27,498
+100
| +0.4% | +$8.09K | 1.8% | 11 |
|
|
2016
Q3 | $2.36M | Buy |
+27,398
| New | +$2.59M | 2.05% | 10 |
|
|
2016
Q2 | – | Sell |
-27,398
| Closed | -$2.87M | – | 42 |
|
|
2016
Q1 | $2.87M | Buy |
27,398
+470
| +2% | +$45.7K | 2.64% | 6 |
|
|
2015
Q4 | $2.6M | Hold |
26,928
| – | – | 2.49% | 8 |
|
|
2015
Q3 | $2.6M | Hold |
26,928
| – | – | 2.67% | 6 |
|
|
2015
Q2 | $2.82M | Hold |
26,928
| – | – | 2.36% | 7 |
|
|
2015
Q1 | $2.78M | Sell |
26,928
-1,132
| -4% | -$115K | 2.39% | 7 |
|
|
2014
Q4 | $2.7M | Buy |
+28,060
| New | +$2.47M | 2.29% | 6 |
|
Other funds holding CVS
CF
HCM
Searle & Co's CVS Position: Q2 2026 in Review
Searle & Co increased its CVS Health (CVS) stake by 0.46% in Q2 2026, buying an estimated $12K and bringing the position to 29,560 shares worth $3.06M. The position accounts for 0.69% of the portfolio, ranked #43.
Searle & Co first reported a position in CVS in Q4 2014 and has held it in 46 quarters since. 937 funds tracked by Wall St. Rank hold CVS as of Q2 2026.
- Searle & Co held 29,560 shares of CVS Health worth $3.06M as of Q2 2026.
- Searle & Co bought 134 CVS Health shares in Q2 2026, an estimated $12K.
- CVS Health made up 0.69% of Searle & Co's portfolio in Q2 2026, its #43 holding.
- Searle & Co first reported a position in CVS Health in Q4 2014 and has held it in 46 quarters since.
- 937 funds tracked by Wall St. Rank held CVS Health as of Q2 2026.
Based on Searle & Co's 13F filing for Q2 2026, filed 27 Jul 2026.